Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Extracellular Vesicles|November 15, 2022
Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen deliveryKai Hu, Elena Palmieri, Karnyart Samnuan, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 26, 2020
Neutrophils Enable Local and Non-Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic HeartJunyi Che, Adrian Najer, Anna K Blakney, et al.
The Journal of Clinical Investigation|November 3, 2004
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccinesShawn M Sumida, Paul F McKay, Diana M Truitt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 21, 2021
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccinesAnna K Blakney, Paul F McKay, Kai Hu, et al.
Cell Reports|September 21, 2018
Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope TrimersYoann Aldon, Paul F McKay, Joel Allen, et al.
Molecular Therapy. Nucleic Acids|January 2, 2023
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccinesJohn S Tregoning, David C Stirling, Ziyin Wang, et al.
Nature Communications|July 11, 2020
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in micePaul F McKay, Kai Hu, Anna K Blakney, et al.
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Nature Communications|May 18, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J Spencer, Paul F McKay, Sandra Belij-Rammerstorfer, et al.
Pageof 9